Patents by Inventor Blas Cerda

Blas Cerda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10068063
    Abstract: Methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data corresponding to an unidentified chemical compound. By restricting the generation of candidate formulas to those having repeating units and/or end units with specified limitations, the methods and apparatus may more efficiently iteratively search for a chemical formula having matching mass spectrometry output within a threshold tolerance. In another aspect, methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data based at least in part upon neutral loss.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: September 4, 2018
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Vsevolod Sergey Rakov, Hayley E. Crowe
  • Publication number: 20170004289
    Abstract: Methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data corresponding to an unidentified chemical compound. By restricting the generation of candidate formulas to those having repeating units and/or end units with specified limitations, the methods and apparatus may more efficiently iteratively search for a chemical formula having matching mass spectrometry output within a threshold tolerance. In another aspect, methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data based at least in part upon neutral loss.
    Type: Application
    Filed: June 30, 2016
    Publication date: January 5, 2017
    Inventors: Blas Cerda, Vsevolod Sergey Rakov, Hayley E. Crowe
  • Patent number: 9410926
    Abstract: Methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data corresponding to an unidentified chemical compound. By restricting the generation of candidate formulas to those having repeating units and/or end units with specified limitations, the methods and apparatus may more efficiently iteratively search for a chemical formula having matching mass spectrometry output within a threshold tolerance. In another aspect, methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data based at least in part upon neutral loss.
    Type: Grant
    Filed: January 28, 2013
    Date of Patent: August 9, 2016
    Assignee: PERKINELMER HEALTH SCIENCES, INC.
    Inventors: Blas Cerda, Vsevolod Sergey Rakov, Hayley E. Crowe
  • Patent number: 8791246
    Abstract: An inventive substrate is provided which includes a substrate compound of formula A-B1-B2-B3-B4: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 is a linker moiety with a free reactive amino group so as to be available for reaction with carboxylic acids or detectable tags; B3 contains a permanently charged element such as a quaternary ammonium group so as to increase sensitivity for mass spectrometry analysis; and B4 of various carbon length conferring specificity amongst individual substrates in detection methods. Also provided is a molecule of the formula B1-B2-B3-B4, with similar structural characteristics to an enzymatic product produced by the action of a target enzyme on an inventive substrate. Further provided are methods for using inventive substrates for detecting enzymatic activity.
    Type: Grant
    Filed: April 3, 2012
    Date of Patent: July 29, 2014
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Mark Norman Bobrow
  • Patent number: 8697450
    Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.
    Type: Grant
    Filed: March 5, 2013
    Date of Patent: April 15, 2014
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy
  • Publication number: 20140045273
    Abstract: Methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data corresponding to an unidentified chemical compound. By restricting the generation of candidate formulas to those having repeating units and/or end units with specified limitations, the methods and apparatus may more efficiently iteratively search for a chemical formula having matching mass spectrometry output within a threshold tolerance. In another aspect, methods and apparatus are provided for the identification of one or more candidate chemical formulas from mass spectrometry data based at least in part upon neutral loss.
    Type: Application
    Filed: January 28, 2013
    Publication date: February 13, 2014
    Applicant: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Vsevolod Sergey Rakov, Hayley E. Crowe
  • Publication number: 20130244269
    Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.
    Type: Application
    Filed: March 5, 2013
    Publication date: September 19, 2013
    Applicant: PERKINELMER HEALTH SCIENCES, INC.
    Inventors: Blas Cerda, Alex Cherkasskiy
  • Patent number: 8513025
    Abstract: This invention relates, inter alia, to detecting and/or measuring succinylacetone and one or more additional biological analytes using mass spectrometry, e.g., tandem mass spectrometry, by derivatizing succinylacetone in a sample by contacting the sample with an extraction solution comprising a C1-3 linear or branched chain monoalcohol and a strong base selected from the group consisting of hydrazine, a modified hydrazine, and hydroxylamine.
    Type: Grant
    Filed: August 9, 2012
    Date of Patent: August 20, 2013
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy, Yijun Li
  • Patent number: 8476414
    Abstract: An inventive substrate is provided which includes a substrate compound of formula A—B1—B2—B3: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 contains a permanently charged element such as a quaternary ammonium group so as to increase proton affinities and ionization efficiencies for mass spectrometry detection efficiencies analysis; and B3 of various carbon length conferring specificities to targeted enzymes. Also provided is a process to detect lysosomal diseases by contacting a sample with the inventive substrate along with an internal standard which is isotope-labeled analog of the product cleaved by a targeted enzyme upon the substrate.
    Type: Grant
    Filed: September 15, 2008
    Date of Patent: July 2, 2013
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventor: Blas Cerda
  • Patent number: 8415162
    Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.
    Type: Grant
    Filed: August 3, 2012
    Date of Patent: April 9, 2013
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy
  • Patent number: 8399186
    Abstract: Provided are methods for detecting a metabolic disorder in an individual using mass spectrometry. One method involves (a) contacting a sample containing (i) a metabolically indicative enzyme and (ii) a metabolic analyte, with a substrate for the enzyme to produce a reaction admixture, under conditions wherein the enzyme is capable of acting on a corresponding substrate to generate a product, and wherein a protease inhibitor is present; (b) contacting the reaction admixture with a reagent that inhibits the ability of the enzyme to act on a corresponding substrate, wherein the metabolic analyte and the product are soluble in the reagent; to produce a test sample and (c) determining the presence or amount of the metabolic analyte and the product contained in the test sample using mass spectrometry, wherein a determined presence or amount of the metabolic analyte and the product correlates with presence or absence of the metabolic disorder.
    Type: Grant
    Filed: January 24, 2012
    Date of Patent: March 19, 2013
    Assignee: PerkinElmer LAS, Inc.
    Inventor: Blas Cerda
  • Publication number: 20120309096
    Abstract: This invention relates, inter alia, to detecting and/or measuring succinylacetone and one or more additional biological analytes using mass spectrometry.
    Type: Application
    Filed: August 9, 2012
    Publication date: December 6, 2012
    Applicant: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy, Yijun Li
  • Patent number: 8318417
    Abstract: Provided are methods for detecting a metabolic disorder in an individual using mass spectrometry. One method involves (a) contacting a sample containing (i) a metabolically indicative enzyme and (ii) a metabolic analyte, with a substrate for the enzyme to produce a reaction admixture, under conditions wherein the enzyme is capable of acting on a corresponding substrate to generate a product, and wherein a protease inhibitor is present; (b) contacting the reaction admixture with a reagent that inhibits the ability of the enzyme to act on a corresponding substrate, wherein the metabolic analyte and the product are soluble in the reagent; to produce a test sample and (c) determining the presence or amount of the metabolic analyte and the product contained in the test sample using mass spectrometry, wherein a determined presence or amount of the metabolic analyte and the product correlates with presence or absence of the metabolic disorder.
    Type: Grant
    Filed: January 7, 2009
    Date of Patent: November 27, 2012
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventor: Blas Cerda
  • Publication number: 20120295361
    Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.
    Type: Application
    Filed: August 3, 2012
    Publication date: November 22, 2012
    Inventors: Blas Cerda, Alex Cherkasskiy
  • Publication number: 20120295295
    Abstract: Methods of evaluating molecular isomers of branched-chain amino acids are featured. The methods can include: derivatizing one or more molecular isomers of branched-chain amino acids in a sample comprising a branched-chain amino acid labeled with one or more heavy atoms as a first standard; adding, to the sample, after derivatization, a nonderivatized or derivatized branched chain amino acid that is labeled with one or more heavy atoms, as a second standard; evaluating the sample using tandem mass spectrometry; and detecting peaks indicative of derivatized and nonderivatized forms of one or more branched-chain amino acids in the sample.
    Type: Application
    Filed: July 16, 2012
    Publication date: November 22, 2012
    Applicant: PERKINELMER LAS, INC.
    Inventors: Blas Cerda, Alex Cherkasskiy, Yijun Li
  • Patent number: 8278116
    Abstract: This invention relates, inter alia, to detecting and/or measuring succinylacetone and one or more additional biological analytes using mass spectrometry.
    Type: Grant
    Filed: April 22, 2011
    Date of Patent: October 2, 2012
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy, Yijun Li
  • Patent number: 8257977
    Abstract: Described herein are methods for determining an amount of an analyte in a test sample. The methods involve preparing a calibration curve using standard samples containing an isotopically-labeled standard in a biological matrix.
    Type: Grant
    Filed: July 26, 2010
    Date of Patent: September 4, 2012
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy
  • Patent number: 8247236
    Abstract: Methods of evaluating molecular isomers of branched-chain amino acids are featured. The methods can include: derivatizing one or more molecular isomers of branched-chain amino acids in a sample comprising a branched-chain amino acid labeled with one or more heavy atoms as a first standard; adding, to the sample, after derivatization, a nonderivatized or derivatized branched chain amino acid that is labeled with one or more heavy atoms, as a second standard; evaluating the sample using tandem mass spectrometry; and detecting peaks indicative of derivatized and nonderivatized forms of one or more branched-chain amino acids in the sample.
    Type: Grant
    Filed: April 11, 2011
    Date of Patent: August 21, 2012
    Assignee: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Alex Cherkasskiy, Yijun Li
  • Publication number: 20120190043
    Abstract: An inventive substrate is provided which includes a substrate compound of formula A-B1-B2-B3-B4: wherein A is a sugar moiety; B1 is a linker moiety allowing the conjugation of moiety A and the remaining structure of the substrate; B2 is a linker moiety with a free reactive amino group so as to be available for reaction with carboxylic acids or detectable tags; B3 contains a permanently charged element such as a quaternary ammonium group so as to increase sensitivity for mass spectrometry analysis; and B4 of various carbon length conferring specificity amongst individual substrates in detection methods. Also provided is a molecule of the formula B1-B2-B3-B4, with similar structural characteristics to an enzymatic product produced by the action of a target enzyme on an inventive substrate. Further provided are methods for using inventive substrates for detecting enzymatic activity.
    Type: Application
    Filed: April 3, 2012
    Publication date: July 26, 2012
    Applicant: PerkinElmer Health Sciences, Inc.
    Inventors: Blas Cerda, Mark Norman Bobrow
  • Publication number: 20120122131
    Abstract: Provided are methods for detecting a metabolic disorder in an individual using mass spectrometry. One method involves (a) contacting a sample containing (i) a metabolically indicative enzyme and (ii) a metabolic analyte, with a substrate for the enzyme to produce a reaction admixture, under conditions wherein the enzyme is capable of acting on a corresponding substrate to generate a product, and wherein a protease inhibitor is present; (b) contacting the reaction admixture with a reagent that inhibits the ability of the enzyme to act on a corresponding substrate, wherein the metabolic analyte and the product are soluble in the reagent; to produce a test sample and (c) determining the presence or amount of the metabolic analyte and the product contained in the test sample using mass spectrometry, wherein a determined presence or amount of the metabolic analyte and the product correlates with presence or absence of the metabolic disorder.
    Type: Application
    Filed: January 24, 2012
    Publication date: May 17, 2012
    Applicant: PerkinElmer Health Sciences, Inc.
    Inventor: Blas Cerda